| CEO: | Carolyn Cross |
| Chairman: | Jean Charest |
| Chief Technology Officer: | Nicolas Loebel |
| Independent Non-Executive Director: | Junaid Bajwa |
| Senior Independent Non-Executive Director: | Jean Duvall |
| Non-Executive Dir: |
| Address: | 888 - 1100 Melville Street, Vancouver, British Columbia, Canada, V6E 4A6 |
| Phone: | +1 604 669 0555 |
| Website: | https://ondinebio.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | CA68234M2058 |
| Currency | UK Pounds |
| Share Price | 8.19p |
| Change Today | 0.19p |
| % Change | 2.40 % |
| 52 Week High | 18.00 |
| 52 Week Low | 8.00 |
| Volume | 904,225 |
| Shares Issued | 518.37m |
| Market Cap | £42.47m |
| Beta | 0.43 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 13:45 | 150,000 @ 8.50p |
| 13:31 | 200,000 @ 8.50p |
| 15:08 | 50 @ 8.00p |
| 14:45 | 143 @ 8.00p |
| 14:43 | 40,000 @ 8.50p |
| Chair | Jean Charest |
| CEO | Carolyn Cross |
You are here: research